The three main key elements used in tissue engineering are the stem cells, morphogens and the scaffolds that, under a conductive external influence (environment) combine in the engineering of tissues. Part 1 of this two-part review article described in detail the various stem cells, morphogens and scaffolds that can be used in tissue engineering. This second article describes the various ways in which these three key elements can be used to engineer biological tissues. A number of strategies and technologies (Figure 1 ) such as, stem cell therapy, gene therapy, guided tissue regeneration, self-assembling systems, etc have been proposed. Clinical Relevance: The field of tissue engineering has recently shown promising results and good future prospects in dentistry for the development of restorations to replace lost tooth structure with a functional replacement.
Tissue engineering is a multidisciplinary approach used for the restoration, maintenance and enhancement of tissue and/or organ function, along with diagnostic applications. The role of the three main key elements (stem cells, morphogens and scaffolds) used for this multidisciplinary approach has already been discussed. Their mutual interplay in a conductive environment aids in engineering of the biological tissues. This second part of the review deals with the strategies that are being used and/or developed to regenerate the tooth tissues with the help of this scientific principle. An array of different and sophisticated strategies and technologies ( Figure 1 ) are being proposed to engineer the tooth tissues. Some are already being used in clinical settings (guided tissue regeneration), some have been tested and applied in laboratory settings (stem cell therapy, self-assembling systems) and a few are in developmental stages (injectable scaffolds, nanoengineering). These strategies, either alone or in combination, have been tried to regenerate and/or engineer tooth tissues like enamel, dentinepulp complex, and periodontal ligament.
This article focuses on the present and future strategies for tissue engineering and discusses the available research data on tissue engineering of the basic dental tissues.
Strategies for tissue engineering
Several different strategies have evolved to regenerate/repair new organs and tissues from lost/damaged tissue structures to attain biologically functional structures or systems.
involve growing a monolayer (or sheet) of cells on a polystyrene growth plate for optimal cell attachment and proliferation. This method involves incubation in an oxygen-rich environment. Usually cell death occurs when the culture is implanted in vivo, unless a reduced oxygen environment is used in the bioreactor. Some type of perfusion bioreactor system can be employed to mimic the in vivo environment more closely. 2 A mechanical challenge results in a better alignment of the cells and a stronger tissue organization as it simulates physiological loading during development and use. Alternatively, the tissues may be developed in a well vascularized location in vivo that aids in developing a circulatory system along with the cells. tissue, or produce a desired compound such as insulin. This strategy has already shown initial success at regenerating small areas of cartilage in temporomandibular joints.
Guided tissue regeneration
Guided tissue regeneration is a surgical procedure that attempts to regenerate lost structures by enhancing the opportunity for one cell type to populate a region over other types of cell to aid in regeneration of original functional tissue. It is currently used to regenerate lost periodontal structures such as the bone, periodontal ligament and connective tissue attachment that support the teeth. The procedure involves placement of a membrane under the mucosa and over the remaining bone. The barrier helps to exclude the faster-growing epithelium and gingival connective tissues during the postsurgical healing phase, thereby allowing the slower-growing periodontal ligament and bone cells to migrate into the protected areas.
Cell induction 1
Various mixtures of growth factors discussed in Part 1 can be directly injected into tissues to target local connective tissue progenitors already present in the region. This causes induction of progenitor cells to generate the desired new tissue in the region. Some of the injected proteins may serve as mitogens and recruit cells to migrate into the area, where they are acted upon by other growth factors to differentiate. Alternatively, they can be delivered to the site using a delivery substrate that releases them over time. One method is to incorporate gene sequence coding for a particular growth factor into a vector (genetically altered virus). After incorporating DNA into their genome, the newly transfected cells begin to replicate the desired growth factor endogenously. This method allows for continuous protein production at the site for a long period of time.
Cells within scaffold matrices
Pre-formed scaffolds composed of bio-resorbable materials promote new tissue formation by encouraging attachment, migration, proliferation, and desired differentiation of connective tissue progenitors into the required new tissue. Often, the cell constructs are grown in a nutrient media supplemented with growth factors necessary for cell and tissue development. At this stage, a mechanical load (either static or dynamic) may be applied to the construct to align the cells to produce a highly organized extracellular matrix. After a suitable period of time in vitro, the entire construct is then implanted in vivo, where the tissue must continue to develop while forming a connection with the existing vascular system. As the tissues develop, the scaffold gradually degrades. The scaffold can serve as a delivery vehicle for the release of therapeutic regulatory compounds in vivo present either on the scaffold surface or encapsulated within the matrix. 3 The scaffold allows adequate access to all cells to metabolic molecules (oxygen, glucose, and amino acids) along with removal of cellular waste products (carbon dioxide, nitrogen compounds, and salts).
Gene therapy 4,5
Gene therapy involves the means of delivering genes encoding for required substrate (growth factors, morphogens or extracellular matrix molecules) to somatic cells in order to stimulate or induce a natural biological process for the regeneration of desired tissue. 6 Either viral or non-viral vectors are used for the delivery of genes. 
Viral vectors
Viral vectors are genetically TissueEngineering altered so that they retain their ability to infect a cell, without causing the disease and by using host cell genetic machinery which results in the formation of desired protein molecules. Adenovirus, retrovirus, herpes simplex virus and lentiviruses 8 are being developed to be used for gene therapy.
Non-viral vectors
The non-viral delivery system uses plasmids, peptides, cationic liposomes, electroporation, and sonoporation for gene delivery to address the issues of immunogenicity and mutagenesis. 4, 9 Major challenges involved in the process are: precise delivery of required genes into target tissue cells; and controlled spatial and temporal gene expression at required levels with minimum of clinical systemic toxicity. Both an in vivo and an ex vivo ( Figure 2 ) approach can be used, depending upon the morphological and physiological characteristics of target tissue, the type vector used, the nature of affected disease and the safety of the procedure. In the in vivo approach, the gene is delivered systemically into the bloodstream or locally to target tissues by injection or inhalation.
Gene therapy is a potential alternative to overcome the disadvantages of protein therapy, such as limiting the half-life of bone morphogenetic proteins (BMPs) which, during their local application, are required in high concentration, along with an optimal scaffold. The successful formation of reparative dentine is observed after application of the BMP family members (BMP and Gdf11). 10, 11 It is also an alternative to in vivo gene therapy in cases of severe inflammation and/or few stem/progenitor cells in the pulp tissue. BMP genes have a great potency to provoke differentiation of pulp cells, even in cases of reversible pulpitis, by using the ex vivo approach for reparative/ regenerative therapy. Limited literature research in this field and the potential for serious health hazards, due to the use of the vector (gene transfer) system, limits its use in clinical endodontic practice as an evidencebased approach. 5 This involves disinfection of root canal systems, using intracanal irrigants (NaOCl and chlorhexidine) along with the placement of antibiotics (eg a mixture of ciprofloxacin, metronidazole and minocycline paste) for several weeks, followed by establishing bleeding into the canal system via overinstrumentation for revascularization of necrotic pulpal tissue. 12 Reimplantation of avulsed teeth with a wider apical opening (1.1 mm) has shown greater chances of revascularization. 13 Mature apices should be instrumented up to 1−2 mm in apical diameter to allow systemic bleeding into root canal systems. This method assumes that the disinfected root canal system, along with the formation of a blood clot, yields a matrix (eg fibrin) in a conductive environment to trap cells that are capable of initiating new tissue formation. It is a practically feasible and an economical approach as it utilizes the currently available instruments and technologies with a lesser risk for immune rejection and disease transmission. However, more clinical studies are required before recommending its use in patients. The concentration and composition of cells trapped may also be variable, depending upon the host tissue and external environment (younger vs older patients; single vs multi-rooted teeth). Another issue is the differential availability of oxygen between the coronal and radicular portions of the pulp, making the treatment outcome highly unpredictable.
Root canal revascularization

Postnatal stem cell therapy 5
This approach uses dental pulp stem cells derived from one of the following sources:  An autologous source (patient's own stem cells);  An allogenic source (purified pulp stem cell line); or  A xenogenic source (animal pulp stem cells) and injecting them into a disinfected and overinstrumented root canal system. The major challenge is to identify and harvest the required postnatal stem cell source, followed by its purification and expansion in desired quantities to aid in regenerative therapy. The use of stem cells only, without the involvement of other key elements (scaffolds and bioactive signalling molecules), may reduce the chances of achieving functional pulp tissue. Cells may also migrate to different locations, leading to the formation of aberrant patterns of mineralization. 
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Pulp implantation 5 This involves the use of many biodegradable membrane filters which are rolled together to form a threedimensional pulp tissue structure from two-dimensional cell cultures. This can then be implanted into disinfected root canal systems. These aggregated sheets of cells are more stable than dissociated cells in the support of cellular proliferation. Individual filters are extremely fragile and therefore difficult to place in root canal systems without breakage. The source of pulp tissue is purified pulp stem cells that are grown on biodegradable polymer nanofibers or on extracellular matrix proteins, such as collagen I or fibronectin.
14 These sheets of cells also lack vascularity, so that a coronal delivery of a scaffold capable of supporting cellular proliferation is required, making the formation of functioning pulp tissue quite unpredictable.
Scaffold implantation 5
This approach is accomplished by the use of a porous polymer scaffold seeded with pulp stem cells that can support cell organization and vascularization, 15 along with growth factors to aid cellular proliferation and differentiation. The scaffold may also contain antibiotics to prevent any bacterial in-growth in the canal systems and can act as a delivery system for pharmaceutical drugs to specific tissues, for example, dentine chips may serve as a matrix and also be a reservoir of growth factors. The scaffolds should be:  Biodegradable;  Highly porous with an adequate pore size to facilitate cell seeding and diffusion of both cells and nutrients;  Able to provide structural integrity within the body;  Able to degrade at a rate that coincides with the tissue formation rate.
The types of scaffold materials available are natural or synthetic, biodegradable or permanent. These include polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL), collagen or fibrin, and polysaccharidic materials, like chitosan or glycosaminoglycans (GAGs). The principal drawbacks are related to the difficulties of obtaining high porosity and regular pore size, as well as some related immune reactions.
Injectable scaffold delivery 5
This approach makes use of hydrogels that are injectable scaffolds and can be delivered by a syringe. 16 This will allow tissue engineered pulp tissue to be administered in a soft three-dimensional scaffold matrix as a polymer hydrogel. These are non-invasive and easy to deliver into root canal systems but have a major limitation of limited control over tissue formation and development, and are not yet proven to be functional. To make hydrogels more practical, research is focusing on making them photopolymerizable to form rigid structures once they are implanted into the tissue site.
Three-dimensional cell printing 5,17
In this approach, an ink-jet-like device is used to dispense layers of cells suspended in a hydrogel. 18 It recreates the structure of the three-dimensional tooth pulp tissue by precisely positioning the cells that mimic the natural tooth pulp tissue structure. This may involve positioning of odontoblasts around the periphery, with fibroblasts in the core. The major challenge involved is the precise orientation of cellular suspensions according to the apical and coronal asymmetry of pulp space, into a functional tissue in vivo, in cleaned and shaped root canal systems. 
Self-assembling systems
Self-assembling systems are ones that automatically construct prespecified assemblies. 20 These can be biological assemblies (eg viruses, cells, tissues, organisms) or non-biological ones (eg crystals). These can produce domains at nano-, micro-, milli-and macroscales. Assemblies can be made from metals, ceramics, polymers, or complex constructions of several materials. Control systems for initiation and/ or propagation may be templates (eg template polymerization of proteins), or they might depend simply on natural rules corresponding to energetically favourable physical, chemical, mechanical, and/or biological events (eg capillary forces, heterogeneous nucleation of crystallization). 21 With the proper use of self-assembling nanoscaffolds, all the key elements of tissue engineering, ie systems outside the body to create scaffolds, provide cells, and create signalling systems, could be managed easily. Working on the same lines oligomeric β-sheetforming peptides that spontaneously undergo hierarchical self-assembly into fibrillar scaffolds in response to specific environmental triggers have provided a new generation of well-defined biopolymers. 22 Under specific conditions, these peptides undergo one-dimensional self-assembly, forming 'nanotapes' that stack in pairs to form ribbons, 23 which in turn can further assemble to form fibrils, and pairs of fibrils intertwine edge-toedge to form fibres with the help of intermolecular H bonding (Figure 3 ). Once assembled, these fibrillar networks can form scaffold-like structures that mirror the biological macromolecules found in extracellular matrices. During enamel development, enamel matrix proteins, themselves known to form selfassembling supramolecular structures that are believed to control the disposition and morphology of the hydroxyapatite crystals, ultimately determine the physiomechanical properties of the mature tissue. Kirkham et al 24 observed that β-sheetforming peptides treatment significantly increased net mineral gain by the lesions, due to both increased remineralization and inhibition of demineralization over a five-day period.
Tissue-engineering of dental tissues 25 
(Figure 4)
Regenerative dentinogenesis makes use of tissue engineering approaches for the repair/regeneration of pulp tissue organ. Usually, this process involves the combined interplay of the three key elements of tissue engineering discussed above.
4,26
Pulp stem/progenitor cells
The pulpal stem cells have the characteristics of extensive self-renewal capacity and maintenance throughout the life of an organism and can be exploited in culturing large numbers of pulp stem cells in vitro for the therapeutic use of regenerative endodontics.
Scaffold
Pulp cells adhere to osteodentine before differentiation into odontoblasts to form tubular dentine in calcium hydroxide pulp-capping. This suggests that there is a prerequisite for a physicochemical surface for odontoblast differentiation.
Morphogen
Morphogens are inductive signals that function as growth/differentiation factors in odontoblast differentiation. Recombinant human BMP2, BMP4, and BMP7 induce reparative/regenerative dentine formation in vivo. Recombinant human insulin-like growth factor-1 with collagen membrane has been shown to induce complete dentine bridging and tubular dentine formation.
Dentine
Demineralized dentine powder is known to possess an intrinsic capability to induce mineralization by the release of extracellular matrix molecules, like bone morphogenetic proteins that can induce reparative dentine formation. 27 Thus, the use of recombinant proteins like BMP7, BMP2 and BMP4 have resulted in the induction of reparative dentine at the sites of pulp exposure within a period of 2 to 4 months. More recently, it has been observed that the ex vivo gene transfer of BMP7, with an adenoviral vector, is a more effective method for inducing reparative dentine formation in teeth that were experimentally inflamed. 28 Challenges include intrinsic difficulties of treating a tooth with an inflamed pulp, to develop suitable carriers as biological inducers of mineralization, and a well-sealed restoration to prevent microleakage. 
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TissueEngineering Enamel
Surfactants, which may mimic the biological action of enamel proteins in enamel development, can be used as reverse micelles or microemulsions to synthesize nanoscale structures that may self-assemble into 'one dimensional' building blocks 29 that are similar in size and composition to natural enamel crystals which can serve as a platform for the development of flowable restorative materials for the restoration of lost enamel. More recently, the Clarkson group 30 created ordered enamel prismlike structures consisting of fluorapatite nanorods under mild hydrothermal conditions without the help of surfactants, proteins or cells. The combination of amelogenin and fluoride has lead to the formation of rod-like apatite crystals with dimensions that resemble the ones observed in natural enamel.
Dental pulp 25 Key elements for dental pulp engineering are:  Molecular signals which induce the differentiation of cells that constitute dental pulps;  Stem cells that will respond to the these signals; and  Scaffolds that will either carry or attract these cells and provide an environment where they can proliferate, differentiate and develop a tissue with the characteristics and function of normal pulp. Challenges include a clinically feasible way of delivering the scaffold (with or without cells), inducing angiogenesis to allow for initial survival of the cells and sustainability of the pulp tissue over time and the correct timing and sequence of morphogenic signals.
Engineering of dental pulp in young, single-rooted and permanent teeth seems more feasible than engineering pulps for teeth with multiple roots, or in older patients where the pulp chamber and root canals may be quite small or inaccessible.
Entire tooth
In 2002, a research group 31 observed for the first time, that enamel, dentine, pulp and a structure that resembled a developing root can be engineered using cells from the tooth germ (pulp of unerupted molars) and a scaffold. Paul Sharpe et al 32 demonstrated that it is possible to engineer teeth of normal size and structure using stem cells. The same group has also demonstrated that adult stem cells of non-dental origin can be used to engineer teeth. Pulp stem cells are an attractive source for dental tissue engineering as they are easy to obtain from the patient and are pleuripotent cells. Challenges faced are the scaffold designs that can provide a conductive environment for tooth development, control over the size and shape of the tooth to be formed and to make this procedure relatively simple, controlled and feasible in the clinical setting.
Aims for the future
Future research can be directed at achieving the following goals in this field:  To determine the gene profiles that signal tooth development programmes for dental tissue engineering purposes and to induce non-odontogenic progenitor stem cells to adopt a tooth differentiation fate. For example, it is possible that, if the molecular profile of epithelial dental stem cell can be determined, it can induce non-dental epithelial tissues to adopt an epithelial dental stem cell fate.  To develop and use alternative scaffold materials and designs to develop predetermined size and shape of tooth tissues.  Bioengineered tooth root formation that resembles natural tooth (crown and root forms).  Brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factors (GDNF) are expressed in dental pulp by pulpal nerve fibres that contribute to angiogenesis, regulate inflammation, strengthen pulpal defence mechanisms and regulate the growth of pulpal fibroblasts. 33 Thus, nerve regeneration could aid in the preservation of odontoblasts as a result of the above-mentioned actions.  Pulpal vasculature contributes immensely towards regeneration of dentine pulp complex, as it plays an important role in regulating inflammation, chemotaxis, proliferation and differentiation of human dental pulp cells. Vascular endothelial growth factor (VEGF) is an excellent regulator of angiogenesis and is known to increase vascular permeability. 34 Therefore, techniques directed towards vascular regeneration may help in the repair and regeneration of the pulp-dentine complex.  To develop nanotechniques or technologies that may aid in tooth regeneration. Dr Sally Marshall's team has been conducting an in-depth investigation of dentine structure, utilizing a unique set of nanoscopic tools. Using a unique x-ray scanning tomography (XTM) they created a three-dimensional profile of normal and carious dentine micro-architecture (1x1x1 µm cube). Their team has explored dentine and modified dentine nanostructure while measuring nanohardness and nanomodulus of nanodomains of tooth structure. 35 
